Expansion of the cancer insurance product 自由診療保険メディコム (private medical treatment insurance Medicom)
First written in FY2017-Q1. 21 of 26 entries say "Restated". Latest entry: 2026-11-11.
No other company in this theme has enough history to compare yet.
- 2026-11-11AdvancedResults
「All of interim-period net sales, operating profit, ordinary profit, and net income attributable to owners of the parent reached record highs.」
当中間期に売上高、営業利益、経常利益、親会社株主帰属中間純利益の4指標で過去最高を達成した。 - 2026-10-04Advancedfinance.yahoo.co.jp
「In the first quarter of the fiscal year ending March 2027, revenue reached a record high, rising 3.6% year on year to ¥298.4 billion, while operating profit increased 3.9% to ¥33.4 billion, marking higher operating earnings.」
It was reported that, in the first quarter of the fiscal year ending March 2027, the company achieved record-high revenue and higher operating profit. - 2026-08-07AdvancedResults
「Net sales for the first quarter reached a record high.」
第1四半期の売上高について、過去最高の実績が追加された。 - FY2026RestatedAnnual report
「During the consolidated fiscal year, the Company promoted sales of the Group's distinctive insurance products, including Fire Insurance Security Discount for businesses, which reflects the reduced risk from installing security systems in premiums; Secom Anshin My Home Insurance, a comprehensive household insurance product; Jiyu Shinryo Hoken Medicom, which covers the actual cost of cancer treatment; and Secom Anshin My Car Insurance, comprehensive automobile insurance with a service under which Secom emergency response personnel rush to the scene of an accident when requested.」
The promotion of sales of the Group’s proprietary insurance product lineup, including Medicom, has continued. - 2026-05-12AchievedResults
「In addition, revenue, operating income, ordinary income and net income attributable to owners of the parent all reached record highs for the period.」
通期で売上高、営業利益、経常利益、親会社株主帰属当期純利益の4指標が過去最高となった。 - FY2026-H1RestatedAnnual report
「In the Insurance Business, revenue was ¥30.6 billion, up 8.5% year on year, due in part to steady sales of Jiyu Shinryo Hoken Medicom, Secom General Insurance Co., Ltd.'s cancer insurance covering private medical treatment, and automobile insurance,」
Steady sales of Jiyu Shinryo Hoken Medicom and automobile insurance continue to contribute to higher revenue in the Insurance Business. - FY2025RestatedAnnual report
「During the consolidated fiscal year, the Company promoted sales of the Group's distinctive insurance products, including Fire Insurance Security Discount for businesses, which reflects the reduced risk from installing security systems in premiums; Secom Anshin My Home Insurance, a comprehensive household insurance product; Jiyu Shinryo Hoken Medicom, which covers the actual cost of cancer treatment; and Secom Anshin My Car Insurance, comprehensive automobile insurance with a service under which Secom emergency response personnel rush to the scene of an accident when requested.」
The promotion of sales of the Group’s proprietary insurance product lineup, including Medicom, has continued. - FY2024RestatedAnnual report
「During the consolidated fiscal year, the Company promoted sales of the Group's distinctive insurance products, including Fire Insurance Security Discount for businesses, which reflects the reduced risk from installing security systems in premiums; Secom Anshin My Home Insurance, a comprehensive household insurance product; Jiyu Shinryo Hoken Medicom, which covers the actual cost of cancer treatment; and Secom Anshin My Car Insurance, comprehensive automobile insurance with a service under which Secom emergency response personnel rush to the scene of an accident when requested.」
The promotion of sales of the Group’s proprietary insurance product lineup, including Medicom, has continued. - FY2023RestatedAnnual report
「During the consolidated fiscal year, the Company promoted sales of the Group's distinctive insurance products, including Fire Insurance Security Discount for businesses, which reflects the reduced risk from installing security systems in premiums; Secom Anshin My Home Insurance, a comprehensive household insurance product; Jiyu Shinryo Hoken Medicom, which covers the actual cost of cancer treatment; and Secom Anshin My Car Insurance, comprehensive automobile insurance with a service under which Secom emergency response personnel rush to the scene of an accident when requested.」
The promotion of sales of the Group’s proprietary insurance product lineup, including Medicom, has continued. - FY2022RestatedAnnual report
「In the consolidated fiscal year, sales of cancer insurance, “Medicom private medical treatment insurance,” offered by セコム損害保険株式会社, remained strong,」
Strong sales of Medicom private medical treatment insurance continue to drive revenue growth in the insurance business. - FY2022-Q2RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance continue to drive revenue growth in the insurance business. - FY2022-Q1RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance continue to drive revenue growth in the insurance business. - FY2021RestatedAnnual report
「During the consolidated fiscal year, the Company promoted sales of the Group's distinctive insurance products, including Fire Insurance Security Discount for businesses, which reflects the reduced risk from installing security systems in premiums; Secom Anshin My Home Insurance, a comprehensive household insurance product; Jiyu Shinryo Hoken Medicom, which covers the actual cost of cancer treatment; and Secom Anshin My Car Insurance, comprehensive automobile insurance with a service under which Secom emergency response personnel rush to the scene of an accident when requested.」
The policy of expanding sales of insurance products, including Medicom, has continued alongside the expansion of the product lineup, including fire insurance, comprehensive household insurance and automobile insurance. - FY2021-Q3RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” automobile insurance and fire insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance, automobile insurance and fire insurance continue to drive revenue growth in the insurance business. - FY2021-Q2RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” automobile insurance and fire insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance, automobile insurance and fire insurance continue to drive revenue growth in the insurance business. - FY2020-Q3RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” fire insurance and automobile insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance, fire insurance and automobile insurance continue to drive revenue growth in the insurance business. - FY2020-Q1RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” and automobile insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance have continued, and automobile insurance is also cited as a strong-performing product. - FY2019RestatedAnnual report
「Strong sales of cancer insurance, “Medicom private medical treatment insurance,” and fire insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance and fire insurance continue to drive revenue growth in the insurance business. - FY2019-Q3RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” and fire insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance and fire insurance continue to be cited as revenue growth drivers for the insurance business. - FY2019-Q2RestatedAnnual report
「In the insurance business, revenue increased due mainly to strong sales of cancer insurance, “Medicom private medical treatment insurance,” and fire insurance offered by セコム損害保険株式会社,」
Strong sales of Medicom private medical treatment insurance and fire insurance continue to be cited as revenue growth drivers for the insurance business. - FY2018-Q3RestatedAnnual report
「Due in part to strong sales of 自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社」
Strong sales of Medicom private medical treatment insurance continue to be cited as a revenue growth driver for the insurance business. - FY2018-Q2RestatedAnnual report
「Due in part to steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社, and fire insurance」
In addition to the existing 自由診療保険メディコム (private medical treatment insurance Medicom), fire insurance is also described as a product with strong sales, while the broader theme of expanding insurance product sales continues. - FY2018-Q1RestatedAnnual report
「Due in part to steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社」
Steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom) are reiterated as a factor contributing to higher revenue in the insurance business. - FY2017-Q3RestatedAnnual report
「Steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社」
Steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom) continue to be cited as a factor contributing to higher revenue in the insurance business. - FY2017-Q2RestatedAnnual report
「Steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社」
Steady sales of 自由診療保険メディコム (private medical treatment insurance Medicom) as an initiative and result in the insurance business are reiterated. - FY2017-Q1First statedAnnual report
「自由診療保険メディコム (private medical treatment insurance Medicom), a cancer insurance product of セコム損害保険株式会社, performed steadily.」
The product name is cited as a factor contributing to higher revenue in the insurance business.